Celanese CORP Form 4 insider transactions

SVP of Acetyls at Celanese Corp, Mark Christopher Murray, reports disposing of 471 shares of common stock to cover tax obligations related to vesting restricted stock units.

Director Kim K.W. Rucker acquired 1,114 shares of Celanese Corp common stock at $156.96 per share as part of an annual restricted stock unit grant.

Director Ganesh Moorthy acquired 1,114 shares of Celanese Corp common stock at $156.96 per share on May 15, 2024, and holds 1,639 shares directly and 1,000 shares indirectly through a revocable living trust.

Director Michael Koenig reports acquiring 1,114 shares of Celanese Corp common stock at $156.96 per share on May 15, 2024, through an annual grant of restricted stock units.

Director Deborah J. Kissire reported acquiring 1,114 shares of Celanese Corp common stock at $156.96 per share on May 15, 2024, through an annual grant of restricted stock units.

Director Jay V. Ihlenfeld acquired 1,114 shares of Celanese Corp common stock at $156.96 per share as part of an annual restricted stock unit grant.

Director David F. Hoffmeister reports acquisition and transfer of Celanese Corp stock, including a grant of restricted stock units and a transfer of shares to a corporation where he is the sole stockholder.

Director Kathryn Hill acquired 1,114 shares of Celanese Corp common stock at $156.96 per share on May 15, 2024, bringing her total holdings to 10,588 shares.

Director Timothy Go acquired 1,114 shares of Celanese Corp common stock at $156.96 per share on May 15, 2024, through an annual grant of restricted stock units.

Director Edward G. Galante acquired 1,114 shares of Celanese Corp common stock at $156.96 per share on May 15, 2024.

Director Jay V. Ihlenfeld reports acquisition of phantom stock representing dividend equivalents on deferred compensation.

Director Edward G. Galante reported the acquisition of phantom stock in Celanese Corp due to dividend equivalents on deferred compensation.

Director Jean S. Blackwell reports acquiring phantom stock representing dividend equivalents on deferred compensation.

Director Kim K.W. Rucker reports the disposition of 1,777 shares of Celanese Corp common stock in exchange for phantom stock, along with an acquisition of additional phantom stock units representing dividend equivalents.

Director Michael Koenig of Celanese Corp reports disposing of 534 shares of common stock to cover tax obligations related to vesting of restricted stock units.

Director Deborah J. Kissire reports disposition of common stock and acquisition of phantom stock related to deferred compensation.

Director Kathryn Hill reports disposition of common stock in exchange for phantom stock and acquisition of additional phantom stock related to dividend equivalents.

Director William M. Brown reports disposition of common stock in exchange for phantom stock and acquisition of additional phantom stock units.

Scott A. Richardson, EVP & COO of Celanese Corp, reports the sale of 4,000 shares of common stock on March 14 and 15, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Thomas Francis Kelly, SVP of EM at Celanese Corp, purchased 1,400 shares of common stock at a price of $156.695 on March 14, 2024.

Mark Christopher Murray, SVP at Celanese Corp, reports purchasing 597 shares of common stock at $156.43 per share on March 8, 2024, bringing his total holdings to 11,600 shares.

Director Kim K.W. Rucker reports acquisition of phantom stock representing dividend equivalents on deferred compensation.

Director Deborah J. Kissire reports acquiring phantom stock representing dividend equivalents on deferred compensation.

Director Jay V. Ihlenfeld reports acquisition of phantom stock representing dividend equivalents in Celanese Corporation.

Director Kathryn Hill reports acquiring phantom stock representing dividend equivalents on deferred compensation.

Director Edward G. Galante reported the acquisition of phantom stock representing dividend equivalents on deferred compensation.

Director William M. Brown reports acquisition of phantom stock representing dividend equivalents on deferred compensation.

Director Jean S. Blackwell acquired phantom stock representing dividend equivalents on deferred compensation.

Celanese Corporation's Chairman and CEO, Lori Ryerkerk, acquired 59,430 nonqualified stock options on February 28, 2024, under the company's Amended and Restated 2018 Global Incentive Plan.

EVP & COO of Celanese Corp, Scott A. Richardson, reports acquisition of 20,543 nonqualified stock options.